Verastem, Inc. (NASDAQ:VSTM) Q4 2025 Earnings Call Transcript March 4, 2026 Verastem, Inc. misses on earnings expectations. Reported EPS is $-0.5 EPS, expectations were $-0.49. Operator: Good ...
The Evo2 genomic language model can generate short genome sequences, but scientists say further advances are needed to write ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results